全球大麻药业市场根据Polaris市场研究的一项新的研究，预计将达到2027美元的5.72亿美元。乐动体育软件最新版那个报告 ”Cannabis Pharmaceuticals Market Share, Size, Trends, Industry Analysis Report, By Product (Epidiolex, Marinol, Cesamet and Sativex); By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Regions; Segment Forecast, 2020 – 2027”详细了解当前市场动态，并提供未来市场增长分析。
Favorable legislation in the market, policies across developed economies, and investments in the research and development for cannabis-infused drugs are the key factors responsible for the market growth. Moreover, technological innovation to decide the accurate dose of cannabis-infused drugs with cutting edge delivery methods to ensure therapeutic and psychoactive events, to contain drug abuse among adults also favoring market growth for cannabis pharmaceuticals. Blockchain technology in the pharmaceutical industry could be used to maintain strain purity and product formulations to have effective treatment for the therapeutic cause and will also enable us to capture dosage data for future considerations, thus technology could also play important role in shaping the market future of the cannabis pharmaceuticals industry.
全球market for cannabis pharmaceuticals is fragmented based on product, distribution channel, and region. In terms of product, the market is segmented into Epidiolex, Marinol, Cesamet, and Sativex. Based on distribution channel, the cannabis pharmaceuticals industry is further bifurcated into hospital, online, and retail pharmacies.
有问题吗？通过点击以下链接在购买此报告之前请求示例或进行查询：//m.ptlymt.com/idustry-analysis/cannabis-pharmaceuticals-market/request-for-sample.
分部亮点
- satiTex.segment accounted for the largest revenue share in 2019 owing to the growing usage of drug for the muscle spasticity. In addition, growing demand for plant-based pharmaceuticals is expected to drive market demand for cannabis pharmaceuticals.
- 基于分销渠道，医院药店分部预计将占2027年的重大份额。高度份额归因于大多数医生推荐从内部药房商店推荐药物的药品，推动大麻药物市场增长。
- 欧洲于2019年占收入的最大份额，因为植物的药物日益增长的需求以及与药用效益相关的大麻相关的提高意识
List of Key Players
- GW Pharmaceuticals.
- 缬草药业
- Insys Therapeutics，Inc。
- Corbus Pharmaceuticals.
- Teva Pharmaceutical
- Avicanna.
- Solvay Pharmaceuticals
- Cannabics Pharmaceuticals
- Others
乐动体育软件最新版Polaris市场研究已经将大麻药品市场报告分段为基于产品，分销渠道和地区
Cannabis Pharmaceuticals, Product Outlook (Revenue – USD Million, 2016 – 2027)
- satiTex.
- 玛丽诺尔
- Cesamet
- Epidiolex
大麻药品，分销渠道前景（收入 - 百万，2016 - 2027）
- 医院药店
- 在线药店
- 零售药房
Cannabis Pharmaceuticals, Regional Outlook (Revenue – USD Million, 2016 – 2027)
- 北美
- 我们。
- 加拿大
- 欧洲
- 法国
- 德国
- UK
- 意大利
- 西班牙
- Netherlands
- Austria
- Asia Pacific
- China
- 印度
- Japan
- 马来西亚
- South Korea
- Indonesia
- Central & South America
- 墨西哥
- 巴西
- 阿根廷
- Middle East & Africa
- UAE
- Saudi Arabia
- 以色列
- South Africa